[rTMS for a patient with derealisation disorder; an experimental treatment]
- PMID: 36912058
[rTMS for a patient with derealisation disorder; an experimental treatment]
Abstract
We describe a 70 year old patient with a history of epilepsy, who developed a derealisation disorder after discontinuing the use of valproic acid. An experimental treatment with rTMS led to a remarkable decrease of his symptoms. We determined our target, the right ventrolateral prefrontal cortex (VLPFC), with the use of neuronavigation. During treatment no complications occurred, specifically no epileptic seizures.